ArticleInternational journal of computer assisted radiology and surgery2019
Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.
Article in International journal of computer assisted radiology and surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Artificial intelligence for prostate cancer detection and risk stratification using transrectal ultrasound: a narrative review.Gland surgery · 2026Review
- Deployment of a real-time prostate cancer confirmation system with Raman spectroscopy: fine-tuning versus test-time adaptation of 1D CNNs.Biophotonics discovery · 2025Article
- Catalyzing Precision Medicine: Artificial Intelligence Advancements in Prostate Cancer Diagnosis and Management.Cancers · 2024Review
- Transfer learning with CNNs for efficient prostate cancer and BPH detection in transrectal ultrasound images.Scientific reports · 2023Article
- Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 1: Raman spectroscopy fiber-optics system and in situ tissue characterization.Journal of biomedical optics · 2022Article
- Coarse label refinement for improving prostate cancer detection in ultrasound imaging.International journal of computer assisted radiology and surgery · 2022Article
- Topology preserving stratification of tissue neoplasticity using Deep Neural Maps and microRNA signatures.BMC bioinformatics · 2022Article
- Current status of deep learning applications in abdominal ultrasonography.Ultrasonography (Seoul, Korea) · 2021Article
- Improving detection of prostate cancer foci via information fusion of MRI and temporal enhanced ultrasound.International journal of computer assisted radiology and surgery · 2020Article
- Multiple instance learning combined with label invariant synthetic data for guiding systematic prostate biopsy: a feasibility study.International journal of computer assisted radiology and surgery · 2020Article
- Pre-clinical evaluation of an image-guided in-situ Raman spectroscopy navigation system for targeted prostate cancer interventions.International journal of computer assisted radiology and surgery · 2020Article
- A review of artificial intelligence in prostate cancer detection on imaging.Therapeutic advances in urologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Prostate cancer (PCa) is the most frequent noncutaneous cancer in men. Early detection of PCa is essential for clinical decision making, and reducing metastasis and mortality rates. The current approach for PCa diagnosis is histopathologic analysis of core biopsies taken under transrectal ultrasound guidance (TRUS-guided). Both TRUS-guided systematic biopsy and MR-TRUS-guided fusion biopsy have limitations in accurately identifying PCa, intraoperatively. There is a need to augment this process by visualizing highly probable areas of PCa. Temporal enhanced ultrasound (TeUS) has emerged as a promising modality for PCa detection. Prior work focused on supervised classification of PCa verified by gold standard pathology. Pathology labels are noisy, and data from an entire core have a single label even when significantly heterogeneous. Additionally, supervised methods are limited by data from cores with known pathology, and a significant portion of prostate data is discarded without being used. We provide an end-to-end unsupervised solution to map PCa distribution from TeUS data using an innovative representation learning method, deep neural maps. TeUS data are transformed to a topologically arranged hyper-lattice, where similar samples are closer together in the lattice. Therefore, similar regions of malignant and benign tissue in the prostate are clustered together. Our proposed method increases the number of training samples by several orders of magnitude. Data from biopsy cores with known labels are used to associate the clusters with PCa. Cancer probability maps generated using the unsupervised clustering of TeUS data help intuitively visualize the distribution of abnormal tissue for augmenting TRUS-guided biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.